Suzuken Co., Ltd. logo

Suzuken Co., Ltd.

9987.T

JPXHealthcareMedical - Distribution

Latest quote

¥5,086

−¥38.00 · -0.74%

Aug 24, 3:30 PM JST

9987.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
JP
CEO
Shigeru Asano
Listed since
Jan 1, 2001
Employees
12,717

Market position

Day range

Current ¥5,086

52-week range

Current ¥5,086

Open
¥5,119
Previous close
¥5,124
Volume
89.9K
0.45× average
Average volume
200.09K
Average daily volume
Market cap
344.01B JPY
Beta
0.23
Market reference 1
50-day average
¥5,033.28
+1.05% above average
200-day average
¥5,719.83
-11.08% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
9.37×
P/B (TTM)
0.82×
P/S (TTM)
0.14×
Dividend yield
1.97%

Profitability & efficiency

Gross margin
7.63%
Operating margin
1.39%
Net margin
1.50%

Financial health

Debt / equity
0.06×
Altman Z-score
3.11
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends9%6%3%-0%Gross margin, FY2022: 7.47%Gross margin, FY2023: 7.76%Gross margin, FY2024: 7.76%Gross margin, FY2025: 8.01%Gross margin, FY2026: 7.74%Operating margin, FY2022: 0.90%Operating margin, FY2023: 1.41%Operating margin, FY2024: 1.46%Operating margin, FY2025: 1.55%Operating margin, FY2026: 1.46%Net margin, FY2022: 0.64%Net margin, FY2023: 0.88%Net margin, FY2024: 1.22%Net margin, FY2025: 1.44%Net margin, FY2026: 1.53%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 7.47%. Gross margin FY2023 7.76%. Gross margin FY2024 7.76%. Gross margin FY2025 8.01%. Gross margin FY2026 7.74%. Operating margin FY2022 0.90%. Operating margin FY2023 1.41%. Operating margin FY2024 1.46%. Operating margin FY2025 1.55%. Operating margin FY2026 1.46%. Net margin FY2022 0.64%. Net margin FY2023 0.88%. Net margin FY2024 1.22%. Net margin FY2025 1.44%. Net margin FY2026 1.53%.

Income trends

Revenue

2.49T JPY+3.61%

Operating income

36.38B JPY-2.02%

Net income

38.14B JPY+10.55%
Income trends across reported periods2.73T JPY1.74T JPY756.07B JPY−232.83B JPYRevenue, FY2022: 2.24T JPYRevenue, FY2023: 2.31T JPYRevenue, FY2024: 2.39T JPYRevenue, FY2025: 2.4T JPYRevenue, FY2026: 2.49T JPYOperating income, FY2022: 20.12B JPYOperating income, FY2023: 32.61B JPYOperating income, FY2024: 34.88B JPYOperating income, FY2025: 37.13B JPYOperating income, FY2026: 36.38B JPYNet income, FY2022: 14.39B JPYNet income, FY2023: 20.35B JPYNet income, FY2024: 29.02B JPYNet income, FY2025: 34.5B JPYNet income, FY2026: 38.14B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 2.24T JPY. Revenue FY2023 2.31T JPY. Revenue FY2024 2.39T JPY. Revenue FY2025 2.4T JPY. Revenue FY2026 2.49T JPY. Operating income FY2022 20.12B JPY. Operating income FY2023 32.61B JPY. Operating income FY2024 34.88B JPY. Operating income FY2025 37.13B JPY. Operating income FY2026 36.38B JPY. Net income FY2022 14.39B JPY. Net income FY2023 20.35B JPY. Net income FY2024 29.02B JPY. Net income FY2025 34.5B JPY. Net income FY2026 38.14B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue2.49T JPY2.4T JPY2.39T JPY2.31T JPY2.24T JPY
Cost of goods sold2.29T JPY2.21T JPY2.2T JPY2.14T JPY2.07T JPY
Gross profit192.53B JPY192.23B JPY185.25B JPY179.7B JPY167.33B JPY
Research and development3.52B JPY3.28B JPY2.95B JPY4.59B JPY
Selling, general, and administrative156.15B JPY151.58B JPY147.09B JPY144.14B JPY142.62B JPY
Operating expenses156.15B JPY155.11B JPY150.37B JPY147.09B JPY147.22B JPY
Interest income158M JPY182M JPY166M JPY171M JPY196M JPY
Interest expense42M JPY41M JPY43M JPY42M JPY51M JPY
Depreciation and amortization12.34B JPY12.06B JPY8.74B JPY8.84B JPY10.02B JPY
Operating income36.38B JPY37.13B JPY34.88B JPY32.61B JPY20.12B JPY
Net income38.14B JPY34.5B JPY29.02B JPY20.35B JPY14.39B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 3 misses, 0 met estimates
Average EPS surprise
+55.49%
11 comparable reports
Latest EPS result
49.99
Estimate 69.72 · Miss by 28.30%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates226.89157.2687.6418.02Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 137.28, estimate 51.64, surprise +165.84%, Beat. Q2 2025, reported May 12, 2025: actual 52.67, estimate 21.2, surprise +148.44%, Beat. Q3 2025, reported Aug 13, 2025: actual 52.63, estimate 64.96, surprise -18.98%, Miss. Q4 2025, reported Nov 10, 2025: actual 175.46, estimate 131.94, surprise +32.98%, Beat. Q1 2026, reported Feb 12, 2026: actual 211.65, estimate 97.2, surprise +117.75%, Beat. Q2 2026, reported May 14, 2026: actual 105.8, estimate 62.14, surprise +70.26%, Beat. Q3 2026, reported Aug 7, 2026: actual 49.99, estimate 69.72, surprise -28.30%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 107.36, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates706.4B648.97B591.54B534.11BQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 641.35B JPY, estimate 632.6B JPY, surprise +1.38%, Beat. Q2 2025, reported May 12, 2025: actual 561.28B JPY, estimate 592.21B JPY, surprise -5.22%, Miss. Q3 2025, reported Aug 13, 2025: actual 592.87B JPY, estimate 636.2B JPY, surprise -6.81%, Miss. Q4 2025, reported Nov 10, 2025: actual 626.57B JPY, estimate 679.23B JPY, surprise -7.75%, Miss. Q1 2026, reported Feb 12, 2026: actual 666.19B JPY, estimate 620.89B JPY, surprise +7.30%, Beat. Q2 2026, reported May 14, 2026: actual 601.02B JPY, estimate 591.57B JPY, surprise +1.60%, Beat. Q3 2026, reported Aug 7, 2026: actual 628.96B JPY, estimate 611.52B JPY, surprise +2.85%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 647.68B JPY, surprise —, Comparison unavailable.

9987.T peers

ETFs holding 9987.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 9987.T

research.disclaimer